A massive new meta-analysis reviewed over 10,000 cannabis-related cancer studies and found that nearly 75% showed therapeutic benefit. From nausea relief to potential tumor suppression, the science is no longer fringe. This isn’t a breakthrough—it’s a reckoning with decades of delay, stigma, and denial. The question now is: what’s still standing in the way?
DEA’s Delay Won’t Stop the Cannabis Revolution
The DEA’s delay in rescheduling cannabis is just a temporary hurdle for an industry and movement that refuses to be slowed down. Cannabis was once part of the counter-culture, now it is the culture. The future of cannabis is bright, and nothing is going to stop it
Cannabis on the Brink: America’s Fight for Medical Marijuana and the Looming Reschedule
Medical marijuana is legal in 38 states, but federal law still classifies cannabis alongside heroin. With rescheduling on the horizon, the push for full legalization intensifies. Explore how these changes could reshape the landscape for patients and the cannabis industry
Cannabis Crossroads: Navigating the Latest Federal and State Reforms
Explore the latest federal and state-level cannabis reforms, including the SAFER Banking Act and new markets in Virginia and Ohio. Discover how these changes could reshape the U.S. cannabis industry.